Cingulate Inc. (NASDAQ:CINGW) Sees Large Increase in Short Interest

Cingulate Inc. (NASDAQ:CINGW) was the recipient of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 9,399 shares, an increase of 281.0% from the February 26th total of 2,467 shares. Based on an average daily volume of 48,976 shares, the days-to-cover ratio is currently 0.2 days.

Cingulate Price Performance

Shares of CINGW opened at $0.04 on Friday. The company’s fifty day moving average is $0.06 and its two-hundred day moving average is $0.05. Cingulate has a 1 year low of $0.02 and a 1 year high of $0.18.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.